Currently, the influence of brusatol on the Nrf2 pathway in pancreatic cancer cells remains unclear, whereas the influence of brusatol on ROS expression in various cancer cells remains controversial. The gene discussed is NFE2L2; the disease is pancreatic neoplasm.